Fluoropolymer-coated Dacron Versus PTFE Grafts for Femorofemoral Crossover Bypass: Randomised Trial

European Journal of Vascular and Endovascular Surgery

Volumn 32, Issue 4, 2006, Pages 431-438

  Eiberg, J P ^a   Roder O ^b   Stahl Madsen, M ^b   Eldrup, N ^a   Qvarfordt, P ^b   Laursen, A ^b   Greve, M ^b   Florenes T ^c   Nielsen, O M ^b   Seidelin, C ^b   Vestergaard Andersen, T ^b   Schroeder, T V ^a  

^a Rigshospitalet   (Denmark)

^b Department of Vascular Surgery ^*  (Denmark)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Femorofemoral bypass; Fluoropassivated Dacron; Patency; PTFE

Indexed keywords

DACRON; POLITEF; POLYMER;

AGED; ANGIOPLASTY; ARTICLE; BYPASS SURGERY; CLAUDICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DACRON IMPLANT; DENMARK; FEMALE; FOLLOW UP; GRAFT PATENCY; HUMAN; ILIAC ARTERY OBSTRUCTION; INTERMETHOD COMPARISON; LIMB ISCHEMIA; LIMB PAIN; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NORWAY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SWEDEN;

AGED; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; FEMALE; FEMORAL ARTERY; FLUOROCARBON POLYMERS; GRAFT OCCLUSION, VASCULAR; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; MALE; POLYETHYLENE TEREPHTHALATES; POLYTETRAFLUOROETHYLENE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; VASCULAR PATENCY;

EID: 33748537382     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.04.018     Document Type: Article

References (29)

1. Vetto R.M. The treatment of unilateral iliac artery obstruction with a transabdominal, subcutaneous, femorofemoral graft. Surgery 52 (1962) 343-345
2. Papadopoulos C.D. Cross-over femorofemoral bypass. Am J Surg 111 (1966) 216-219
3. Kalman P.G., Hosang M., Johnston K.W., and Walker P.M. The current role for femorofemoral bypass. J Vasc Surg 6 (1987) 71-76
4. Buchbinder D., Pasch A.R., Schuler J.J., Meyer J.P., Dillon B.C., Rollins D.L., et al. Efficacy of femorofemoral bypass for intermittent claudication. Clinical and hemodynamic assessment. Am J Surg 152 (1986) 215-219
5. Rhee R.Y., Gloviczki P., Cambria R.A., and Miller V.M. Experimental evaluation of bleeding complications, thrombogenicity and neointimal characteristics of prosthetic patch materials used for carotid angioplasty. Cardiovasc Surg 4 (1996) 746-752
6. Schmitt D.D., Bandyk D.F., Pequet A.J., and Towne J.B. Bacterial adherence to vascular prostheses. A determinant of graft infectivity. J Vasc Surg 3 (1986) 732-740
7. Rosenman J.E., Pearce W.H., and Kempczinski R.F. Bacterial adherence to vascular grafts after in vitro bacteremia. J Surg Res 38 (1985) 648-655
8. Harris J.M., and Martin L.F. An in vitro study of the properties influencing Staphylococcus epidermidis adhesion to prosthetic vascular graft materials. Ann Surg 206 (1987) 612-620
9. Cintora I., Pearce D.E., and Cannon J.A. A clinical survey of aortobifemoral bypass using two inherently different graft types. Ann Surg 208 (1988) 625-630
10. Lord R.S., Nash P.A., Raj B.T., Stary D.L., Graham A.R., Hill D.A., et al. Prospective randomized trial of polytetrafluoroethylene and Dacron aortic prosthesis. I. Perioperative results. Ann Vasc Surg 2 (1988) 248-254
11. Post S., Kraus T., Muller-Reinartz U., Weiss C., Kortmann H., Quentmeier A., et al. Dacron vs. polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trial. Eur J Vasc Endovasc Surg 22 (2001) 226-231
12. Mamode N., and Scott R.N. Graft type for femoro-popliteal bypass surgery. Cochrane Database Syst Rev (2000) CD001487
13. Lau H., and Cheng S.W. Is the preferential use of ePTFE grafts in femorofemoral bypass justified?. Ann Vasc Surg 15 (2001) 383-387
14. Robinson B.I., Fletcher J.P., Tomlinson P., Allen R.D., Hazelton S.J., Richardson A.J., et al. A prospective randomized multicentre comparison of expanded polytetrafluoroethylene and gelatin-sealed knitted Dacron grafts for femoropopliteal bypass. Cardiovasc Surg 7 (1999) 214-218
15. Abbott W.M., Green R.M., Matsumoto T., Wheeler J.R., Miller N., Veith F.J., et al. Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group. J Vasc Surg 25 (1997) 19-28
16. Ao P.Y., Hawthorne W.J., Vicaretti M., and Fletcher J.P. Development of intimal hyperplasia in six different vascular prostheses. Eur J Vasc Endovasc Surg 20 (2000) 241-249
17. TASC Working Group. Management of peripheral arterial disease (PAD) - TransAtlantic Inter-Society Concensus. J Vasc Surg 31 (2000) S1-S296
18. Criado E., Burnham S.J., Tinsley Jr. E.A., Johnson Jr. G., and Keagy B.A. Femorofemoral bypass graft: analysis of patency and factors influencing long-term outcome. J Vasc Surg 18 (1993) 495-504
19. Newman A.B., Shemanski L., Manolio T.A., Cushman M., Mittelmark M., Polak J.F., et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 19 (1999) 538-545
20. Johnson W.C., and Lee K.K. Comparative evaluation of externally supported Dacron and polytetrafluoroethylene prosthetic bypasses for femorofemoral and axillofemoral arterial reconstructions. Veterans Affairs Cooperative Study #141. J Vasc Surg 30 (1999) 1077-1083
21. van der Vliet J.A., Scharn D.M., de Waard J.W., Roumen R.M., van Roye S.F., and Buskens F.G. Unilateral vascular reconstruction for iliac obstructive disease. J Vasc Surg 19 (1994) 610-614
22. Hinchliffe R.J., Alric P., Wenham P.W., and Hopkinson B.R. Durability of femorofemoral bypass grafting after aortouniiliac endovascular aneurysm repair. J Vasc Surg 38 (2003) 498-503
23. Mingoli A., Sapienza P., Feldhaus R.J., Di Marzo L., Burchi C., and Cavallaro A. Femorofemoral bypass grafts: factors influencing long-term patency rate and outcome. Surgery 129 (2001) 451-458
24. Pursell R., Sideso E., Magee T.R., and Galland R.B. Critical appraisal of femorofemoral crossover grafts. Br J Surg 92 (2005) 565-569
25. Schneider J.R., Besso S.R., Walsh D.B., Zwolak R.M., and Cronenwett J.L. Femorofemoral versus aortobifemoral bypass: outcome and hemodynamic results. J Vasc Surg 19 (1994) 43-55
26. Kim Y.W., Lee J.H., Kim H.G., and Huh S. Factors affecting the long-term patency of crossover femorofemoral bypass graft. Eur J Vasc Endovasc Surg (2005)
27. Harris J.P., Flinn W.R., Rudo N.D., Bergan J.J., and Yao J.S. Assessment of donor limb hemodynamics in femorofemoral bypass for claudication. Surgery 90 (1981) 764-773
28. Veterans Affairs Cooperative Study. Donor limb vascular events following femoro-femoral bypass surgery. Arch Surg 126 (1991) 681-685
29. Devine C., and McCollum C. Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial. J Vasc Surg 40 (2004) 924-931